Joinn Laboratories (China) Co Ltd
Company Profile
Business description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Contact
A5 Rongjing East Street
Beijing Economic-Technological Development Area
Beijing100176
CHNT: +86 1067869966
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
2,510
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,683.40 | 50.00 | 0.58% |
CAC 40 | 7,887.08 | 19.32 | -0.24% |
DAX 40 | 21,520.33 | 14.63 | 0.07% |
Dow JONES (US) | 44,556.04 | 134.13 | 0.30% |
FTSE 100 | 8,594.47 | 23.70 | 0.28% |
HKSE | 20,597.09 | 192.87 | -0.93% |
NASDAQ | 19,654.02 | 262.06 | 1.35% |
Nikkei 225 | 38,831.48 | 33.11 | 0.09% |
NZX 50 Index | 12,844.59 | 60.45 | -0.47% |
S&P 500 | 6,037.88 | 0.00 | 0.00% |
S&P/ASX 200 | 8,416.90 | 42.90 | 0.51% |
SSE Composite Index | 3,229.49 | 21.11 | -0.65% |